These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 11321726)

  • 21. Pathologic Considerations in Gastroenteropancreatic Neuroendocrine Tumors.
    Bellizzi AM
    Surg Oncol Clin N Am; 2020 Apr; 29(2):185-208. PubMed ID: 32151355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Imaging of secretory tumors of the gastrointestinal tract.
    ElGuindy YM; Javadi S; Menias CO; Jensen CT; Elsamaloty H; Elsayes KM
    Abdom Radiol (NY); 2017 Apr; 42(4):1113-1131. PubMed ID: 27878636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Controversies of gastroenteropancreatic neuroendocrine tumor pathology diagnosis].
    Sasano H; Kasajima A
    Nihon Shokakibyo Gakkai Zasshi; 2014 Dec; 111(12):2280-5. PubMed ID: 25482903
    [No Abstract]   [Full Text] [Related]  

  • 24. Epidemiology of gastroenteropancreatic neuroendocrine tumours.
    Fraenkel M; Kim MK; Faggiano A; Valk GD
    Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):691-703. PubMed ID: 23582913
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imaging features of malignant abdominal neuroendocrine tumors with rare presentation.
    Corrias G; Monti S; Horvat N; Tang L; Basturk O; Saba L; Mannelli L
    Clin Imaging; 2018; 51():59-64. PubMed ID: 29448120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Gastroenteropancreatic neuroendocrine tumors: what must the pathologist know and do in 2014?].
    Scoazec JY; Couvelard A;
    Ann Pathol; 2014 Feb; 34(1):40-50. PubMed ID: 24630636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Pancreatic neuroendocrine tumors and von Hippel-Lindau disease].
    Musso C; Paraf F; Petit B; Archambeaud-Mouveroux F; Valleix D; Labrousse F
    Ann Pathol; 2000 Mar; 20(2):130-3. PubMed ID: 10740008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Genetic profile of gastroenteropancreatic neuroendocrine tumors].
    Cabezas Agrícola JM
    Endocrinol Nutr; 2009 Apr; 56 Suppl 2():16-9. PubMed ID: 19627765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic and therapeutic role of endoscopy in gastroenteropancreatic neuroendocrine neoplasms.
    Attili F; Capurso G; Vanella G; Fuccio L; Delle Fave G; Costamagna G; Larghi A
    Dig Liver Dis; 2014 Jan; 46(1):9-17. PubMed ID: 23731843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
    Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
    BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neuroendocrine tumors of the stomach. Pathogenesis, classification and clinical aspects].
    Bordi C; Azzoni C; D'Adda T; Caruana P; Carlinfante G
    Pathologe; 1997 Jul; 18(4):313-21. PubMed ID: 9380606
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reassessing the grade of gastroenteropancreatic neuroendocrine neoplasms.
    Klimstra DS
    Endocrine; 2016 Jul; 53(1):4-6. PubMed ID: 27150611
    [No Abstract]   [Full Text] [Related]  

  • 33. Introduction to a revised clinicopathological classification of neuroendocrine tumors of the gastroenteropancreatic tract.
    Rindi G; Capella C; Solcia E
    Q J Nucl Med; 2000 Mar; 44(1):13-21. PubMed ID: 10932598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Classification and pathology of gastroenteropancreatic neuroendocrine neoplasms.
    Klöppel G
    Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S1-16. PubMed ID: 22005112
    [TBL] [Abstract][Full Text] [Related]  

  • 35. G3 GEP NENs category: are basic and clinical investigations well integrated?
    Milione M; Fazio N
    Endocrine; 2018 Apr; 60(1):28-30. PubMed ID: 28733935
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New and Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors.
    Phan AT; Kunz PL; Reidy-Lagunes DL
    Clin Adv Hematol Oncol; 2015 May; 13(5 Suppl 5):1-18; quiz 1 p following 18. PubMed ID: 26430956
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinicopathologic Features of Gastroenteropancreatic Neuroendocrine Tumors: A Single-center Experience.
    Akın Telli T; Esin E; Yalçın Ş
    Balkan Med J; 2020 Aug; 37(5):281-286. PubMed ID: 32573179
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinicopathologic characteristics of 127 cases of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) studied in an oncology hospital].
    Alvarado-Cabrero I; de Anda-González J; Hernández-Hernández B; Mantilla-Morales A; Valencia-Cedillo R; Medrano-Guzmán R
    Rev Gastroenterol Mex; 2012; 77(4):174-80. PubMed ID: 23142406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement.
    Coriat R; Walter T; Terris B; Couvelard A; Ruszniewski P
    Oncologist; 2016 Oct; 21(10):1191-1199. PubMed ID: 27401895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gastroenteropancreatic neuroendocrine tumors: current perspectives and future challenges.
    Garcia-Carbonero R
    Cancer Metastasis Rev; 2014 Mar; 33(1):343-4. PubMed ID: 24357057
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.